(S)-α-(trifluoromethyl)phenylalanine | 129939-31-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: (S)-α-(trifluoromethyl)phenylalanine
• 英文别名: α-CF3-Phe；(S)-2-amino-2-benzyl-3,3,3-trifluoropropanoic acid；(2S)-2-azaniumyl-2-benzyl-3,3,3-trifluoropropanoate
• CAS: 129939-31-7
• 化学式: C₁₀H₁₀F₃NO₂
• mdl: MFCD07779885
• 分子量: 233.19
• InChiKey: RDQOEQUFZYLLRT-VIFPVBQESA-N

物化性质

• 熔点：
  200 °C
• 沸点：
  327.9±42.0 °C(Predicted)
• 密度：
  1.371±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  Methyl alpha-(trifluoromethyl)phenylalaninate 在 氢氧化钾 作用下， 以 甲醇 为溶剂， 生成 (S)-α-(trifluoromethyl)phenylalanine
  参考文献：
  名称：

  First Method for the Preparation of Strongly Electrophilic Chiral Sulfinimines, and Applications in Asymmetric Synthesis

  摘要：

  DOI：

  10.1080/10426509908546463

文献信息

• [EN] AZASULFURYLPEPTIDE-BASED CD36 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS CD36 À BASE D'AZASULFURYLPEPTIDES ET UTILISATIONS DE CEUX-CI
  申请人：RSEM LTD PARTNERSHIP

  公开号：WO2016029324A1

  公开（公告）日：2016-03-03

  Novel azasulfuryl-containing peptidomimetics capable of inhibiting CD36 activity are disclosed. Use of these azasulfuryl-containing peptidomimetics for the treatment of CD36-related diseases, disorders or conditions, including TLR2-mediated inflammatory disease, disorder or condition, and methods of obtaining such azasulfuryl-containing peptidomimetics, are also disclosed.

  揭示了能够抑制CD36活性的新型含氮硫酰基的肽类模拟物。还揭示了利用这些含氮硫酰基的肽类模拟物治疗与CD36相关的疾病、紊乱或状况，包括TLR2介导的炎症性疾病、紊乱或状况的用途，以及获取这种含氮硫酰基的肽类模拟物的方法。
• Lipid probes and uses thereof
  申请人：THE SCRIPPS RESEARCH INSTITUTE

  公开号：US10168342B2

  公开（公告）日：2019-01-01

  Disclosed herein are methods, compositions, probes, assays and kits for identifying a lipid binding protein as a drug binding target. Also disclosed herein are methods, compositions, and probes for mapping a ligand binding site on a lipid binding protein, identification of lipid binding proteins, generating drug-lipid binding protein profiles, high throughput drug screening, and identification of drugs as potential lipid binding protein ligands.

  披露了用于识别脂质结合蛋白作为药物结合靶点的方法、组合物、探针、检测和试剂盒。此外，还披露了用于绘制脂质结合蛋白上的配体结合位点、识别脂质结合蛋白、生成药物-脂质结合蛋白轮廓、高通量药物筛选以及识别作为潜在脂质结合蛋白配体的药物的方法、组合物和探针。
• [EN] PIPECOLIC LINKER AND ITS USE FOR CHEMISTRY ON SOLID SUPPORT<br/>[FR] LIEUR PIPÉCOLIQUE ET SON UTILISATION POUR UNE CHIMIE SUR SUPPORT SOLIDE
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2010023295A1

  公开（公告）日：2010-03-04

  The present invention relates to a pipecolic linker and its use as a solid-phase linker in organic synthesis. Said pipecolic solid-phase linker may be used for coupling functional groups chosen between primary amines, secondary amines, aromatic amines, alcohols, phenols and thiols. In particular, said pipecolic solid-phase linker may be used for peptide or pseudopeptide synthesis, such as the reverse N to C peptide synthesis or the retro-inverso peptide synthesis, or for the synthesis of small organic molecules.

  本发明涉及一种吡啶哌酸链连接剂及其在有机合成中作为固相连接剂的用途。所述吡啶哌酸固相连接剂可用于将功能基团偶联在一起，这些功能基团可选择为一级胺、二级胺、芳香胺、醇、酚和硫醇。特别地，所述吡啶哌酸固相连接剂可用于肽或伪肽合成，例如反向N到C肽合成或反向逆转肽合成，或用于小有机分子的合成。
• Age Inhibitors
  申请人：Potier Pierre

  公开号：US20080249030A1

  公开（公告）日：2008-10-09

  The invention relates to a compound having general formula I, wherein: X represents CH 2 , C═O, C═S or CHOH, X represents CH 2 , C═O, C═S or CHOH, R 1 represents an amino acid which is optionally substituted by one or more halogen atoms, preferably fluorine, or by one or more CF 3 groups and n=0.1 or 2, or X represents CH 2 , C═O, C═S, CHOH, R 1 represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, preferably fluorine, or by one or more CF 3 groups and n=0 or 1, or XR 1 represent PO 3 H or SO 3 H and n=0.1 or 2; R 2 represents H, XR 1 , an alkyl group at C 1 -C 6 , an aralkyl group at C 1 -C 6 or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH 2 , a carboxylic group COOH, one or more halogen atoms, preferably fluorine, or one or more CF 3 groups; or the pharmaceutically-acceptable addition salts, isomers, enantiomers and diastereoisomers of said compound, mixtures thereof, and pharmaceutical or cosmetic compositions comprising same and the use thereof as an AGE-inhibitor drug that traps reactive carbonyl compounds.

  该发明涉及一种具有一般式I的化合物，其中：X代表CH2、C═O、C═S或CHOH，X代表CH2、C═O、C═S或CHOH，R1代表一种氨基酸，该氨基酸可以选择性地被一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代，n=0.1或2，或者X代表CH2、C═O、C═S、CHOH，R1代表含有两个氨基酸的肽，每个氨基酸可以选择性地被一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代，n=0或1，或者XR1代表PO3H或SO3H，n=0.1或2；R2代表H、XR1、C1-C6的烷基、C1-C6的芳基烷基或芳基，其中烷基、芳基烷基和芳基可以被氨基NH2、羧基COOH、一个或多个卤素原子（优选为氟）或一个或多个CF3基团取代；或者所述化合物的药学上可接受的加合盐、异构体、对映体和二对映异构体，其混合物，以及包含其的制药或化妆品组合物及其作为捕捉反应性羰基化合物的AGE抑制剂药物的用途。
• REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION, AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS
  申请人：The Scripps Research Institute

  公开号：US20200392550A1

  公开（公告）日：2020-12-17

  Disclosed herein are compositions, methods, cells, engineered microorganisms, and kits for increasing the production of proteins or polypeptides comprising one or more unnatural amino acids. Further provided are compositions, cells, engineered microorganisms, and kits for increasing the retention of unnatural nucleic acids encoding the unnatural amino acids in an engineered cell, or semi-synthetic organism.

  本文揭示了一种用于增加含有一个或多个非天然氨基酸的蛋白质或多肽的生产的组合物、方法、细胞、工程微生物和试剂盒。此外，还提供了一种用于增加编码非天然氨基酸的非天然核酸在工程细胞或半合成生物体中的保留的组合物、细胞、工程微生物和试剂盒。